LIFT-AD
Athira Pharma’s Stock Plummets Following Disappointing Alzheimer’s Drug Trial Results
Athira Pharma, Alzheimer’s disease, fosgonimeton, LIFT-AD study, stock crash
Actionable Insights Powered by AI
Athira Pharma, Alzheimer’s disease, fosgonimeton, LIFT-AD study, stock crash